Adamas Pharmaceuticals Inc (ADMS) Jumps 9.93% on January 22

Equities Staff |

Adamas Pharmaceuticals Inc (ADMS) was among the biggest gainers on the Russell 2000 for Friday January 22 as the stock popped 9.93% to $22.80, representing a gain of $2.06 per share. Some 246,294 shares traded hands on 2,126 trades, compared with an average daily volume of 318,323 shares out of a total float of 18.42 million. The stock opened at $21.41 and traded with an intraday range of $23.20 to $20.44.

After today's gains, Adamas Pharmaceuticals Inc reached a market cap of $420.02 million. Adamas Pharmaceuticals Inc has had a trading range between $31.84 and $12.73 over the last year, and it had a 50-day SMA of $19.54 and a 200-day SMA of $20.01.

Adamas Pharmaceuticals Inc is a specialty pharmaceutical company, is focused on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. Its portfolio includes Namzaric and Namenda XR.

Adamas Pharmaceuticals Inc is based out of Emeryville, CA and has some 59 employees. Its CEO is Gregory Went.

For a complete fundamental analysis analysis of Adamas Pharmaceuticals Inc, check out’s Stock Valuation Analysis report for ADMS. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

GSV Capital Corp

GSV Capital Corp is an externally managed, non-diversified closed-end management investment company. The Company has elected to be treated as a business development company.

Private Markets


Snapchat is the fastest way to share a moment with friends. The mobile app, allows users to not only share photos with friends but also control how long they can…


Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…